Neutral
Barinthus Biotherapeutics appoints Douglas Swirsky as CFO
Barinthus Biotherapeutics has announced the appointment of Douglas Swirsky as Chief Financial Officer and principal accounting officer, effective May ...
BRNS
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest BRNS News
Neutral
Research BRNS on:
Ad Space